Understanding Clinic Practices for Human Papilloma Virus Vaccination Series Completion in Clinics That Provide Primary Care: Survey of Clinic Managers in Iowa.
Rates for human papilloma virus (HPV) vaccination are low across the United States. Evidence-based-practices to increase immunization coverage have been recommended by public health organizations, yet many primary care clinics do not follow these practices. The purpose of this study was to examine if primary care clinics use these best practices to promote completion of the HPV vaccine series for their adolescent patients. Understanding the prevalence of evidence-based immunization strategies is key to increasing vaccination coverage.



We mailed 914 surveys to clinic managers of clinics that provide primary care in Iowa. The survey content was based on immunization strategies related to clinic practice and policies that have been proven effective to promote the completion of the HPV vaccination series.



Survey responses from 127 clinics were used in the final analysis. Most clinics always used the state's immunization information system to record HPV vaccinations (89.4%). Over a quarter of clinics (27.6%) did not use any type of reminder or recall system to alert parents or providers that an HPV vaccine was due, and 35.0% did not give the vaccine at sick visits.



Clinics need to focus more on the recommended logistics and processes to ensure that patients receive the entire HPV vaccination series. Survey results indicate that clinics are not consistently implementing the recommended best practices to ensure that vaccination series are completed.
From the *Public Policy Center, †Department of Community and Behavioral Health, College of Public Health, ‡ College of Nursing, and §Department of Sociology, College of Liberal Arts & Sciences, University of Iowa, Iowa City, IA.
Natoshia M
NM
Askelson
Stephanie W
SW
Edmonds
Elizabeth T
ET
Momany
Mesay A
MA
Tegegne
D000293:Adolescent; D000554:Ambulatory Care Facilities; D002648:Child; D019538:Health Care Surveys; D006801:Humans; D007114:Immunization; D007484:Iowa; D027383:Papillomaviridae / Q000276:immunology* / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D011216:Practice Management, Medical; D011320:Primary Health Care; D014611:Vaccination
D053918:Papillomavirus Vaccines